7227 N. 16th Street Suite 160 Phoenix, AZ 85020
7227 N. 16th Street Suite 160 Phoenix, AZ 85020
Working in fertility for over a decade, and serving as an ART program supervisor for the past seven years, Brian has proved himself to be an expert embryologist. He has extensive experience in all facets of the embryology laboratory, including: ICSI, Day 3 and Day 5 blastocyst embryo development, assisted hatching, vitrification of oocytes and embryos, and PGD. In addition to the technical procedures, Brian is the chief compliance officer and represents Boston IVF with CLIA, CAP, SART, and FDA licensure and inspections. He is highly regarded by these agencies as having successfully guided centers on both coasts to the highest level of recognition and achievement. Brian has been a great asset to TWEB with both his laboratory expertise and his knowledgeable consulting.
Rebecca De La Cruz joined The World Egg Bank in 2009. Rebecca’s prior association with The World Egg Bank was as an egg donor who enjoyed helping families. She is a dedicated member of our team, and is resourceful, organized, creative and efficient. After screening thousands of our egg donors, her goal is to accept the best and ensure that each donor has a very positive experience. She serves as a resource for donors through every step of the screening and donation process. Rebecca interfaces with Intended Parents, who enjoy regular updates on their donor, and with doctor’s offices across the US to manage donor screening, monitoring, travel, and post-retrieval care. She accommodates special screening requirements nationally and internationally requested of our IP’s doctors. Her knowledge of the donor process is unsurpassed after years of experience with The World Egg Bank.
Caderina Carrizosa graduated from Arizona State University with a double major in Mathematics and Biological Sciences. Caderina’s diligent work ethic and friendly, personable approach to clients and vendors makes her an efficient and effective Financial Manager. She also was an egg donor three times prior to her employment with The World Egg Bank and understands the emotional and financial difficulties our Intended Parents often face.
Shannon’s background is in education and her work in the Early Childhood Education for 13 years as a teacher has given her significant background in planning and working within structured time-sensitive management systems. As a member of the school’s management team, she worked with many students in their 20’s to counsel them on career choices. She has exceptional communication skills, organizational and computer skills and human resource management training. Her energy and commitment to serving customers is clearly demonstrated in her relationship with our clients.
Anna Hasselbring graduated from Northern Arizona University with a double major in Advertising and Public Relations. Anna’s previous work at a marketing firm in Chicago has given her a unique perspective that she now uses to educate and counsel potential egg donors. She also has 6+ years in child care and customer service giving her exceptional people skills. Anna’s outgoing, caring personality along with her passion regarding egg donation allows her to connect with new donors and guide them through the application process.
Tonya Heilbrun graduated from Northern Arizona University with a Bachelor’s degree in Marketing. She is a perfect fit for our company as she has a very unique story of her own. Tonya was one of The World Egg Banks recipients back in 2003 when Diana Thomas (Founder and CEO) was still operating her fresh donor agency, X and Y Consulting. Tonya has amazing twin boys as a result of her donor egg experience. Six short months after the birth of her twins, she “miraculously” became pregnant with her third biological son. Tonya has many years of experience in the customer service industry. In 2009, she started a small company with her sister called Use Your Marbles. This was a marble reward system for children that she designed and marketed while staying at home with her boys when they were younger. With Tonya’s personal experience, she has the empathy and compassion needed to assist our clients while going through all the highs and lows of the infertility process.
Dr. Harton received his Bachelor of Science degree from James Madison University and his Ph.D. at the University of Kent, Canterbury, UK. His thesis title was: Facilitating the widespread use of preimplantation genetic diagnosis and screening through best practice and novel technology development. Following a long career in the field of Reproductive Sciences, including both laboratory management and IVF practice management posts, Dr. Harton is currently the Group Senior Vice President, Commercial Development at Progyny. He is responsible for Progyny’s commercial operations including sales, marketing, and customer service operations across the products of Fertility Authority, EggBanxx, IVFAdvantage and The Eeva test, the first and only FDA-cleared test to use time lapse imaging combined with their proprietary algorithm to aid in embryo selection during IVF. Gary has been involved in a number of exciting breakthroughs in the field of reproductive genetics including performing the first clinical preimplantation genetic diagnosis (PGD) for an autosomal dominant disease (Marfan syndrome) and performing the first clinical PGD for spinal muscular atrophy (SMA). In addition, Dr. Harton was involved in the team that pioneered non-disclosing Huntington disease PGD where a patient at risk for HD could ensure that their children were free from the mutation without discovering their own HD status. He was also involved in the team that discovered and patented Karyomapping, a revolutionary new technology allowing practically any genetic defect to be diagnosed in embryos using one single array-based test. Dr. Harton is certified by the American Board of Bioanalysis (ABB) as a Technical Supervisor, in Molecular Diagnostics and is a member of the American Society for Reproductive Medicine (ASRM) as well as the European Society of Human Reproduction and Embryology (ESHRE), and Preimplantation Genetic Diagnosis International Society. Dr. Harton has also served as Chair of the Steering Committee for the ESHRE PGD, and has been an author on numerous peer reviewed scientific articles, abstracts and book chapters.
Richard C Wagner M.S., C.G.C Geneticist for The World Egg Bank.
Rick graduated from the Pennsylvania State University in 1975 and received his masters degree in human genetics and counseling from Rutgers University in 1976. Rick is a Certified Genetic Counselor (CGC), a diplomate of the American Board of Medical Genetics, and a charter member of the American Board of Genetic Counseling. Rick has over 30 years genetic counseling experience specializing in prenatal genetic diagnosis and counseling. He provides egg donor family history evaluations for our donors. Rick has also served in an advisory capacity to the Arizona Department of Health Genetic Services Committee, the Greater Arizona Chapter of the March of Dimes, The Arizona Association of Retarded Citizens, the Arizona Hemophilia Association, and the Arizona Committee to Combat Huntington’s Disease.
Brian received his M.Sc. from The Jones Institute for Reproductive Medicine at Eastern Virginia Medical School in 2012. He has over 10 years of experience in Assisted Reproductive Technologies (ART), with eight years as laboratory supervisor.
Brian has experience in all facets of ART: Embryology, andrology, and immunoassay. He received his training in Connecticut and arrived in Phoenix in 2007. Since then, he has successfully represented clinics with major compliance agencies such as: CAP, CLIA, FDA, and SART. Since 2010, his focus has been on vitrification and warming of oocytes and he has performed over 500 vitrification cycles with proven, consistent pregnancy rates from clinics around the world.
In addition to his role in the embryology laboratory, Brian works as a consultant with various clinics and embryology organizations. He has consulted on the construction of numerous embryology laboratories throughout the United States. He founded and organized the Desert Southwest Embryology Association, a local professional group for embryologists in the Phoenix metropolitan area. He also serves on the organizing committee for the Southwest Embryology Summit, an annual conference for embryologists throughout the western United States.
Psychological Pathways +1.928.776.7885. Dr. Lemberg completed his Ph.D. studies in the field of clinical psychology at the University of Maryland (APA approved) in 1977. His dissertation was titled “Measuring Community Mental Health Needs and Community Competence: A Cost-Effective Analysis of Three Assessment Methods”. His undergraduate degrees were in psychology, sociology and a minor in anthropology; where he received highest distinction honors.From 1972 to 2000 Dr. Lemberg participated in various consulting positions, teaching positions, and psychotherapy and clinical administration positions. His consulting work (1972 – 2012) focused on women’s and children’s issues, specifically eating disorders and, more recently, chemical dependency. Dr. Lemberg has taught at various colleges and universities, namely University of Maryland and Arizona State University, where he served as adjunct professor of psychology from 1980 to 1989.
Dr. Lemberg’s psychotherapy and clinical administration career is highlighted by his work at Camelback Hospitals and Mental Health Center where he was responsible for implementing, developing and directing the clinical programming for two psychiatric hospitals and a community mental health center. He founded the Arizona Coalition for Responsible Mental Health Care; a coalition of psychiatrists and psychologists to promote responsible mental health care benefits. From 1982 to 1998 he served as the CEO of Psychological Pathways, which is a multidisciplinary group practice based in three cities in Arizona. The group focuses on treatment of eating disorders, family psychotherapy, attention deficit disorder, brain and spinal injury as well as hospital/organizational consultation.Dr. Lemberg’s work has appeared in over 41 papers and publications worldwide. He has made over 100 presentations to a variety of groups primarily on the topic of eating disorders. Other topics include ADHD, autism, couples and family therapy, OCD, psychological testing and traumatic brain injury. He was interviewed by over 40 media outlets on the topic of eating disorders from 1980 to 2010.
Over his career he has been a member or received certifications/honors from over 30 respected groups. He is an Associate Editor for Eating Disorders:The Journal of Treatment and Prevention.Dr. Lemberg has been in private practice since 1981. He treats children, adolescents, adults, couples and families. He has provided psychological testing and evaluation for The World Egg Bank since 1997.
Dr. Lemberg’s prolific career and experience over a wide range of psychological fields provides the experience The World Egg Bank requires to ensure its egg donors are well prepared for their egg donation cycle.
Dr. Kovacs is a world renowned specialist in the fields of reproductive gynecology, endocrinology, and infertility. He has over 30 years experience in IVF, ovulation induction, male subfertility, donor insemination, and microsurgery. Dr. Kovacs currently serves as the International Medical Director of Monash IVF. His postgraduate credentials include: MD, FRCOG, FRANZCOG, CREI, FAICD, and Graduate Certificate in Management from Macquarie Graduate School of Management.He has been President of The Fertility Society of Australia, Family Planning Australia, Family Planning Victoria, and Chairman of The IVF Directors’ Group of Australia. Professor Kovacs was a Councilor of the College of Obstetrics and Gynecology for a period of six years, having chaired its Continuing Education and Women’s Health Committees. He is a director of ACCESS, Australia’s national infertility network.He is a professor of Obstetrics and Gynecology at Monash University and has published more than 150 scientific papers, over 30 chapters in textbooks, has written five books for the public, and edited seven textbooks.
Dr. Mayer received his Ph.D. in Reproductive Physiology from The Johns Hopkins University in 1980. He joined the IVF program at the Jones Institute in Norfolk in 1982 and is presently Professor in the Department of Ob/Gyn, in the Jones Institute at Eastern Virginia Medical School. He currently serves as the Clinical Laboratory Director of the Embryology Lab at The Jones Institute (since 1994); the offsite Laboratory Director at the Jones Institute of Western Penns/Allegehny Healthcare System in Pittsburgh, PA (since 2003); and also the offsite Laboratory Director at the University Reproductive Care, Depart of Ob/Gyn, University of Washington (Seattle)(since 2011).Since 2004, he has also served as both Commissioner and Deputy Commissioner for the College of American Pathologists in the ASRM/CAP Reproductive Laboratory Accreditation Program.Dr. Mayer is both an instructor and the Director of the Online Masters Program in Embryology and Andrology at the Jones Institute for Reproductive Medicine. Since 2004, this program has produced over 150 graduates and this number continues to grow as the 11th class has recently begun its course of study.Dr. Mayer has been a member of the American Society for Reproductive Medicine (ASRM) since 1984. He has served on numerous ASRM committees. He was the first chairman of the Reproductive Laboratory Technology Professional Group (1991 – 92); a Legislative Monitor for ASRM Government Office from 1990 – 1997; Co-Chairman of the ASRM Government and Public Relations Committee (1999-2001); a member of ASRM Practice Committee Task Force for the Revision of Guidelines for Gamete and Embryo Donation (2001-2002); and chair of the “EmbryoMail” Advisory Committee (2008 – present). He received the Distinguished Service Award from the American Society of Reproductive Medicine in Oct 2006. He has also received the ASRM 2010 Service Award for having continuously contributed 10 or more years of service to the ASRM.He has also served in various capacities on the SART Executive Council. He served as a representative Laboratory Director on the SART Executive Council from 1995-1998. He was a member of the SART International Committee 1997-2001, Co-Chairman of the Government and Public Relations Committee from1998-2001, Special member for FDA affairs (2001-2006), Representative of the CAP/ASRM’s Lab accreditation program (2004-2010), and Laboratory Representative for the National Coalition for Oversight of Assisted Reproductive Technology (NCOART) (1996-2010).Finally, he has served with a number of organizations, relevant to reproductive medicine. These include National Institute of Health – NIH (member of the “Working Group of the Advisory Committee to the Director NIH” creating NIH guidelines and oversight structure for research involving human pluripotent stem cells. 1999-00) He was a member of National Board of RESOLVE (2001-2005).
Dr. Kuwayama earned his PhD. in biology at the School of Veterinary Science at Hokkaido University in Japan in 1997. His doctoral thesis work involved vitrification of embryos and mammalian oocytes, achieving the world’s first pregnancies with vitrified bovine eggs. Moving into the field of human embryology, he obtained the first babies in Japan and the US with vitrified oocytes.
He has also perfected the technique and apparatus being used by most successful programs in the world (in 40 countries). He is currently the CEO of a private research institute, Repro-Support Medical Research Center in Japan, with a staff of 65 embryologists and 13 scientists studying vitrification and other related areas of expertise. Dr. Kuwayama is also the academic and technical supervisor of the embryology laboratory at Kato Ladies Institute, one of the largest IVF centers in the world, which currently undertakes 21,000 IVF cycles per year.
He has vitrified more than 200,000 human oocytes and embryos in his own center and others he works with. Dr. Kuwayama has sat on many international academic and professional boards, occupied Directorships, and invited lectures including:
Kimball O. Pomeroy is a clinical embryologist who has directed several clinical laboratories throughout the United States. He was trained in Bristol, England as a human embryologist and prior to that was educated at Colorado State University, where he received a Ph.D. in Animal Physiology, and then worked at the Salk Institute for Biological Studies where he did post-doctoral work in molecular biology. At the Salk Institute, Dr. Pomeroy was a molecular biologist and worked with Dr. Glen Evans on the Human Genome Project (chromosome 11) and did work in transgenics.
Dr. Pomeroy has worked as a consultant for several projects in Mexico, Nepal, China, Bolivia and the Bahamas. He has served as a member of the SART Executive Board, Chair of the Reproductive Laboratory Technician’s Group, Chair of the College of Reproductive Biology and a founding member of the Regulatory Task Force and the Southwest Embryologist Summit.
Dr. Pomeroy has lectured at many scientific meetings and has been involved in the organization and presentations at several symposia for the education of embryologists. He has coauthored numerous papers, mostly dealing with the detection of embryo toxins and cryopreservation. Recently he has coauthored several papers on the risks of cross-contamination of microbes during storage of tissue in liquid nitrogen, the usefulness of embryo morphology in predicting pregnancy and the source of microbial contamination during embryo culture.
Dr. Pat McShane completed her training in OB GYN and Reproductive Medicine and Infertility at Brigham and Women’s Hospital in 1983, earning her REI boards in 1985. She completed her Clinical Fellowship at Harvard Medical School. Dr. McShane served as the Assistant Professor of Obstetrics and Gynecology at Harvard and as an Associate Professor at UMass Medical Center.
Coincidentally, after completing her boards in the mid-eighties, the historical beginnings of IVF in the US commenced. Dr. McShane served as the Medical Director of IVF at the Brigham, and soon thereafter at the Reproductive Science Center of New England during the introduction of many key clinical services, including embryo cryopreservation, oocyte donation, and ICSI in the mid-eighties and nineties. Later, she would be involved in the launch of pre-implantation genetic diagnosis and screening and an early trial of oocyte maturation. Dr. McShane was listed as one of Boston’s top doctors. She is one of the first reproductive specialists to bring in-vitro fertilization technology to the US.
From 2007 to 2013, Dr. McShane practiced at the University of Colorado Health Sciences Center where she spearheaded the oocyte vitrification clinical trial, involving immediate thawing and transfer of vitrified oocytes for infertile couples, showing equivalency with fresh oocytes. A current project involves developing CME materials for oncologists to increase acceptance of fertility preservation options, including oocyte and embryo vitrification. She recently earned a Certificate in Global Public Health at the Colorado School of Public Health.
Dr. McShane has served on the Board of Directors of Integramed, a management company for fertility practices, and as the President of the New England Fertility Society. Other memberships include: Offices and Committee Assignments for ASRM, SART Abstract Committee and Women’s Council.
Dr. McShane is the author of numerous medical reports, reviews, and book chapters, including:
• McShane PM, Schiff I. IVF and embryo transfer–what we’ve learned. Contemporary Ob/Gyn 1986;28:125.
• McShane PM. “Controlled Ovarian Hyperstimulation for Assisted Reproductive Technologies”: New Horizons in Reproductive Medicine.
• Coutifaris C and Mastroianni L (eds). Lancs LA6 2 LA, UK, Parthenon Publishing, 1997: ISBN 1-85-70-793-6.
• McShane PM, Danforth A, Carson R. Oocyte donation-an efficient therapy for perimenopausal infertility. Presented at the District ACOG, Meeting New Rhode Island, 1995.
• Carson RS, Burgess CM, Glatstein IZ, Singer N, Cunningham DL, McShane PM, Wood DS. Pre-implantation Genetic Diagnosis and
The World Egg Bank 9 Cryopreservation of Embryos. Presented at the 532rd ASRM Annual Meeting, Cincinnati, Ohio, 1997.
• IVF in women over 42 years old: Is using autologous oocytes a reasonable option? Presented at the 59th ASRM Annual Meeting, San Antonio, TX 2003.
• Outcome in women over 35 years of age undergoing consecutive cycles of in vitro fertilization (IVF) using the gonadotropin-releasing hormone antagonist protocol. ASRM Meeting, New Orleans, LA 2006.
In 1985 Diana Thomas graduated Magna Cum Laude from Arizona State University with a Master’s Degree in Architectural History. Her undergraduate work was completed in Canada, where she has dual citizenship. From 1979 to 1996 Ms. Thomas held a number of leadership positions in the study and preservation of historic architecture in both the United States and Canada. She was promoted to the head of Alberta’s Provincial Inventory of Historic Sites, where she gained more than seven years of managerial experience, initiated innovations in her field, obtained private funding, and implemented new database systems nation-wide. In 1992 Ms. Thomas’ managerial and administrative talents brought her back to Arizona, where she continued to develop and manage multi-million dollar historic preservation granting funds and projects.
Throughout her career, Ms. Thomas struggled with infertility. After finding her own egg donor in 1995, she gave birth to a healthy child in 1996 who was one of the first 100 babies born with donor eggs in the US. After that success, infertility doctors contacted her to find egg donors for their other patients. In 1997 Ms. Thomas combined her extensive knowledge of the infertility industry, IVF, and donor IVF processes, with her administrative and managerial skills to form one of the first egg donor recruiting/ matching agencies in the US: X and Y Consulting. Ms. Thomas grew X and Y internationally while compiling a donor roster of hundreds of potential egg donors. During this time she traveled internationally, meeting infertility professionals at every level. Her managerial skills led her to cultivate healthy relationships with industry fertility specialists, business professionals, and vendors, including psychologists, genetic counselors and laboratories. Thomas’ compassion and experience has helped match thousands of couples with egg donors worldwide.
In 2004 Ms. Thomas, along with Drs. Jeffrey Boldt and James Akin, founded Cryo Eggs International (CEI). Dr. Boldt was one of the pioneers in developing egg freezing technology. During this time a world-renowned medical and scientific advisory board was assembled to support the company’s vision. CEI provided the frozen donor oocytes that led to the birth of the first baby in the world born from eggs provided by a commercial egg bank in 2005.
As CEO of the company, Thomas and her co-founders developed a new business model, daily operating systems, and a customer relations focus on service, without any business model precedents. The key portions of medical and scientific development were managed by Medical Director Dr. Patricia McShane who is well respected in the infertility community. Ms. Thomas worked with her managerial team to implement quality control, best practices, daily operational functions, and growth opportunities with new technological developments. Ms. Thomas continued to further develop relationships throughout the industry.
In 2009 Ms. Thomas merged X and Y and CEI into the company today known as The World Egg Bank, Inc. All egg donor services, from traditional fresh donor cycles to banking vitrified oocytes began operating under one umbrella. Through Ms. Thomas’ direction The World Egg Bank now offers the best in egg donor technologies for parents-to-be. The World Egg Bank provides the highest-level experience and expertise available in the US.